Holmström, M O
Hjortsø, M D
Ahmad, S M
Met, Ö
Martinenaite, E
Riley, C
Straten, P http://orcid.org/0000-0002-4731-4969
Svane, I M
Hasselbalch, H C
Andersen, M H
Article History
First Online: 20 October 2016
Competing interests
: MOH, HCH and MHA have filed a patent regarding the <i>JAK2</i>V617F mutation as a target for cancer immune therapy. The patent has been transferred to University Hospital Zealand, Zealand Region and Copenhagen University Hospital at Herlev, Capital Region according to Danish Law concerning inventions made at public research institutions. The remaining authors declare no conflict of interest.